Skip to main content Skip to section navigation Skip to footer
Stock Information
chevron_left Back to CastleBiosciences.com
Castle Biosciences, Inc. IR Home
  • Overview
  • News & Events keyboard_arrow_down
    • Press Releases
    • IR Events
    • Presentations
    • In The Media
    • Annual Meeting
    • Email Alerts
  • Company Info keyboard_arrow_down
    • Company Profile
    • Executive Team
    • Annual Reports & Proxy
    • Contacts
    • FAQ
  • Financial Info keyboard_arrow_down
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data keyboard_arrow_down
    • Quote & Chart
    • Historical Data
    • Analyst Coverage
  • SEC Filings keyboard_arrow_down
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance keyboard_arrow_down
    • Governance Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Corporate Responsibility
  • Resources keyboard_arrow_down
    • Scientific Evidence
  • Stock Information
  • chevron_leftBack to CastleBiosciences.com

In The Media

News & Events

  • Press Releases
  • IR Events
  • Presentations
  • In The Media
  • Annual Meeting
  • Email Alerts
Jan 31, 2024
Practical Dermatology: A Biologic Test for Cutaneous Squamous Cell Carcinoma
Jan 26, 2024
Clinical Lab Products: Test to Guide Radiation Therapy for Skin Cancer Patients Could Save Millions in Medicare Costs
Jan 19, 2024
Dermatology Times: Cost-Saving 40-GEP Test in ART Decision-Making Reduces Over-Treatment
Jan 18, 2024
Clinical Trials Arena: Study Finds Cutaneous Squamous Cell Carcinoma Test Could Save US Medicare Almost $1BN
Jan 16, 2024
Health & Pharma: Castle's Innovative Gene Expression Tests Transform Clinical Decisions for Skin Cancer
Jan 9, 2024
Gastro Broadcast Independent GI Radio: Episode #50: Predicting Cancer in Patients with Barrett’s Esophagus (a new test can help GI docs identify who is at greater risk)
Dec 5, 2023
Dermatology Times: DecisionDx-Melanoma Survey Reveals Patient Care Insights Among NPs and PAs
Dec 4, 2023
NS Medical Devices: Castle’s DecisionDx-Melanoma Test Impacts NPs/PAs’ Patient Care Decisions, Says Study
Dec 1, 2023
Practical Dermatology: NPs and PAs Value Prognostic Information From DecisionDx-Melanoma
Dec 1, 2023
Future of Personal Health (Personalized Medicine independent supplement by Mediaplanet to USA Today): How a Genomic Test is Empowering Better, More Personalized Melanoma Care
rss_feed RSS
  • Previous Pagearrow_back
  • Page 1
  • …
  • Page 12
  • Page 13
  • Page 14
  • Page 15
  • Page 16
  • Page 17
  • Page 18
  • Page 19
  • Page 20
  • Page 21
  • …
  • Page 26
  • Next Pagearrow_forward
  • emailEmail Alerts
  • location_cityCompany Profile
  • contact_pageContacts
  • rss_feedRSS News Feed
©2026 Castle Biosciences, Inc. All Rights Reserved.
  • Privacy Policy
  • Disclaimer
  • Sitemap
  • Accessibility Statement

Market Data copyright © 2026 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.